Biologicals and biosimilars
Biosimilaire geneesmiddelen: Algemene informatie voor patiënten in België
Les médicaments biosimilaires: Informations générales pour les patients en Belgique
Registered Biosimilar Products in Belgium (update of March 2022)
Biosimilars: Information for healthcare professionals and patients (EMA video)
Patient Registries
Community Led Data Generation and Patient Registries
Drug Development
Drug development lifecycle
Ethics, Legislation, and Conflicts of interest
Ethics, Legislation, and Conflicts of interest
EUPATI BE Publications
Improving Patient Involvement in the Lifecycle of Medicines: Insights From the EUPATI BE Survey
Reflections on the Collaborative Fight Against COVID-19
Patient Preferences
Patient Preferences
Patient Reported Outcomes
Patient Reported Outcome Measures (PROMs)
Pharmacovigilance
Pharmacovigilance: What does it mean?
Providing input during a patient advisory board
Attention points
The role of patients in Ethics Committees
Interview with the EC Chair
Interview with a patient representative (1)
Interview with a patient representative (2)
Interview with the EC Coordinator
Subscribe to Eupati Belgium
Newsletter copy
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Ok
